Top Analytics Companies in Chicago, IL (238)

Market Expansion: Feedback suggests the February 2026 acquisition of Dhauz expanded Quantum Rise’s footprint across North America, Europe, and South America, indicating active international growth. Company materials and third-party profiles describe a combined workforce exceeding 100, reinforcing the expansion signal.

Product Line Growth: Feedback suggests the launches of QR/OS and QR/OnCall reflect broadening offerings beyond traditional projects into more repeatable and potentially recurring services. These developments indicate deliberate effort to scale delivery models and diversify how value is delivered.

Strategic Partnerships: Feedback suggests being named an OpenAI Select Partner and citing relationships with Azure, AWS, Databricks, and Snowflake strengthen market positioning and delivery capability. Such partnerships can enhance credibility and help win implementation work.

Strong Revenue Growth: Revenue is described as having doubled between 2019 and 2022, with consecutive Inc. 5000 placements in 2023 and 2024 reinforcing a multi-year expansion trajectory. As a result, growth appears to be more than a one-off spike across that period.

Investor Backing & Capital Strength: Growth-capital from Boathouse Capital in February 2025 is presented as financing to scale services, enter new markets, and pursue targeted expansion. This capital support signals external confidence in the next stage of the company’s growth.

Market Expansion: Operations have extended beyond the U.S. to London and Bulgaria, the Chicago headquarters footprint has increased, and the Mashey acquisition broadened capabilities and reach. These moves indicate increasing geographic capacity and service delivery scale.

Diversified Revenue Streams: The company operates multiple brands—CreditNinja (consumer lending), NinjaCard (banking/credit), and EDGE (B2B analytics)—creating several avenues to monetize. This breadth extends it beyond a single-product lender and provides multiple channels for growth.

Product Line Growth: Expansion into business-to-business analytics through EDGE, including its 2023 shift to consumer reporting agency status, indicates ongoing product development. Reported coverage of 3M+ credit applications and $500M+ in associated originations underscores traction for newer offerings.

Strong Hiring & Retention: Active recruitment in 2026 across strategy, operations, product, and data roles, alongside roughly 142 employees listed on LinkedIn, points to continued investment in capability. Hiring across lending, analytics, and operations suggests scaling rather than mere maintenance.

Market Expansion: Lender participation expanded to 76 by the first half of 2026 alongside broader credit‑union access through core banking and loan‑origination integrations, increasing distribution reach. Reported consumer coverage rose to 5 million, indicating a widening data network that can support adoption across target markets.

Product Line Growth: New cash‑flow scores and an upgraded Early Payment Default Score, plus added lead‑screening and expanded cash‑flow analytics, extend coverage across acquisition, underwriting, and post‑origination workflows. This broadened suite signals investment in deeper use cases and potential for greater usage within existing accounts.

Strategic Partnerships: Combining cash‑flow intelligence with Socure’s identity and fraud signals and integrating within ecosystems like Jack Henry Symitar and Sync1 enhances capability and lowers adoption friction. These alliances strengthen value to lenders and open additional channels for scale.

Strong Revenue Growth: Revenue surpassed $1 billion in Q3 2026 for the first time, and annual revenue rose from about $2.1 billion in 2023 to $3.15 billion in 2025, with the first nine months of 2026 continuing to climb. This trajectory reflects momentum across multiple periods rather than a single-quarter spike.

Profitability: Net income and adjusted EPS increased faster than revenue in recent periods, and the net revenue margin improved year over year. These patterns point to expanding earnings alongside top-line growth.

Diversified Revenue Streams: Growth is broad-based across small-business and consumer lending, with both originations, receivables, and segment revenues rising in Q3 2026. The small-business portfolio represents a meaningful share of receivables and continues to scale.

Strong Revenue Growth: Reported annual recurring subscription and service revenue grew by more than 220% in 2025, resulting in ARR more than tripling. The increase is attributed to new and expanding relationships with private‑equity sponsors and their portfolio companies.

Market Expansion: Sponsor partnerships are described as having doubled, broadening commercial reach across private‑equity networks. The company also scaled geographically, adding offices in locations such as Chicago, New York, Toronto, Dallas, and Bengaluru.

Product Line Growth: New offerings include the Astradis platform, an AI‑powered pricing suite, expanded healthcare functionality, and the launch of Astra Labs. These additions broaden the addressable market and signal continued investment in AI‑driven solutions.

Strong Revenue Growth: Company disclosures point to multi‑year top‑line expansion, with independent credit commentary anticipating continued gains. The scale of the installed healthcare network reinforces commercial traction over time.

Market Expansion: Recent launches of a Consumer Health Network and programmatic advertising capabilities extend reach beyond traditional pharmaceutical clients and open new buying channels. These moves indicate active growth into adjacent advertiser categories within healthcare settings.

Investor Backing & Capital Strength: A definitive agreement to be acquired by a global private‑equity firm underscores institutional confidence and adds resources to accelerate network growth and product innovation. The transaction highlights access to capital to support scaling.

Strong Hiring & Retention: Headcount and hiring momentum are evident, with third-party estimates showing growth from roughly the mid‑teens of thousands in 2024 to 20,000+ by 2025–2026 and plans to hire thousands, alongside new capacity such as the Hyderabad operations center. This suggests the company is scaling delivery and talent depth across geographies.

Innovation-Driven Growth: The firm has expanded into AI and digital offerings, including its ZAIDYN platform, acquisitions like Digital Additive and Torrent Consulting, and launches such as Myelo developed with the International Myeloma Foundation. These moves indicate investment beyond traditional consulting into scalable, tech‑enabled services.

Market Expansion: A dedicated mid‑cap pharmaceutical vertical and the opening of an operations center in Hyderabad point to deliberate expansion in target segments and delivery footprint. These steps signal efforts to broaden served markets and strengthen execution capacity.

Strong Revenue Growth: Feedback suggests ARR surpassed $500M in 2023 and was described as approaching $600M in 2024, indicating meaningful scaling of recurring revenue. Company statements also highlight strong growth in power and renewables since 2021.

Market Expansion: Feedback suggests multiple acquisitions (e.g., Spatial Business Systems, PDS exchange assets, A2D well log library) and launches (Enverus ONE, Minerals Marketplace) broaden capabilities into utilities, operational data, and AI-driven workflows. These moves extend reach beyond traditional oil and gas into power and renewables.

Investor Backing & Capital Strength: Feedback suggests Blackstone agreed to acquire the company in 2025 at a multibillion-dollar valuation, signaling institutional confidence and potential resources for further growth. Prior backing by Hellman & Friedman and Genstar also indicates sustained capital support.

Strong Revenue Growth: Subscription revenue is reported to have grown 38% year over year in 2024, following 40% growth in 2023. These company-reported figures, alongside record quarters, indicate rapid scaling of the recurring-revenue base.

Customer Loyalty & Retention: Customer retention is described as above 97% in 2024. Such durability in the installed base supports recurring revenue while enabling expansion through additional product adoption.

Innovation-Driven Growth: New AI products are gaining traction, with 26 AI Agent deals signed in less than six months after launch and an expanding catalog of agents. This adoption signals ongoing investment and customer demand for AI-powered pricing capabilities.

Resilient & Sustainable Growth: Revenue continues to rise year over year, with recent quarters showing steady low–double-digit expansion and management guiding to continued growth in 2026. Feedback suggests the business is prioritizing balanced expansion over hypergrowth.

Cost & Operational Efficiency: Operating performance has improved, with GAAP losses narrowing and non-GAAP operating income and margins moving higher. Guidance points to a stronger exit margin by year-end 2026, indicating tighter cost control and operating leverage.

Diversified Customer Base: The company serves tens of thousands of customers across more than 100 countries, and the number of higher-ARR customers has increased. This breadth, alongside upmarket traction, supports ongoing expansion across segments.

Strong Hiring & Retention: Workforce expansion is evident, with Prolaio reporting 32 new hires in 2025 and continuing to recruit across technical and customer-facing roles. These signals point to organizational scaling backed by ongoing capacity investment.

Product Line Growth: Product capabilities advanced with the launch of the OCORO study and an FDA 510(k) clearance for the eVO2peak module in 2025. These developments broaden the digital cardiovascular biomarker portfolio and can support wider clinical use.

Strategic Partnerships: The 2025 acquisition by Kardigan ties Prolaio’s cardiovascular data platform directly to active drug-development programs. This connection creates avenues for expanded clinical deployments and operational scale.

Product Line Growth: The platform spans operational intelligence, behavioral coaching, conversion optimization, self-service enhancement, compliance management, and conversational guidance, indicating expansion beyond a narrow voice-analytics tool. Company materials through 2025–2026 also highlight automated QA and coaching capabilities that broaden the suite.

Strategic Partnerships: Relationships and integrations involving Lumen, Five9, Speechmatics, and a 2026 SymTrain collaboration point to an expanding ecosystem and co-developed solutions. These connections create additional routes to customers and embed the technology within established contact-center platforms.

Market Expansion: Inclusion in Lumen’s Contact Center Intelligence offering and a SymTrain solution available to both companies’ customers suggest widening distribution in the contact-center market. Ongoing participation in industry events and regional tech profiles reinforces active market presence.

Market Expansion: Expansion into higher education and financial institutions, coupled with the integration of Syntellis and the acquisition of c. myers, broadened capabilities and reach. This indicates widening commercial avenues beyond the core healthcare base.

Innovation-Driven Growth: New AI-powered offerings—Predictive Analytics and Financial Decision Intelligence—were launched within the StrataJazz platform. These additions signal sustained product investment to deepen value and use cases.

Diversified Customer Base: Strata reports serving more than 2,300 organizations across healthcare, higher education, and financial institutions. This spread reduces reliance on a single sector and provides multiple paths for growth.

Strong Revenue Growth: Recent financial results highlight sustained top-line expansion with rising quarterly revenue and management increasing full‑year guidance, indicating momentum across 2025 and into 2026.

Diversified Revenue Streams: Growth is coming from both diagnostics and data licensing/AI applications, with testing volumes and data contracts expanding rather than reliance on a single line of business.

Customer Loyalty & Retention: Reported net revenue retention above 100% and sizable remaining contract value suggest existing pharmaceutical customers are deepening engagements.

Strong Revenue Growth: Record performance is cited in 2024 and continued into the first half of 2025, with revenue and operating profit both increasing and momentum described as ongoing.

Strong Market Position & Advantage: The company is described as gaining market share even during a soft toy market, supported by a defensible system-of-play moat and broad appeal across age groups.

Innovation-Driven Growth: Frequent new set waves, adult-oriented lines, and selective digital integrations (including major gaming partnerships) are positioned as expanding engagement and sustaining demand.